Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Jun 2013 12:59 PM
RNS
Director/PDMR Shareholding
10 Jun 2013 12:59 PM
RNS
TR-1: Notification of Major Interest in Shares
10 Jun 2013 07:00 AM
RNS
Director's Share Purchase
06 Jun 2013 11:45 AM
RNS
Result of AGM
06 Jun 2013 07:00 AM
RNS
Change of Adviser and Broker
06 Jun 2013 07:00 AM
RNS
Management and Board change
05 Jun 2013 10:43 AM
RNS
TR-1: Notification of Major Interest in Shares
03 Jun 2013 07:00 AM
RNS
Clinical Trial Update
24 May 2013 10:00 AM
RNS
BLOCK LISTING RETURN
16 May 2013 07:00 AM
RNS
Interim Management Statement
09 May 2013 09:00 AM
RNS
Update from ARVO 2013
03 May 2013 02:00 PM
RNS
Holding(s) in Company
03 May 2013 02:00 PM
RNS
Director/PDMR Shareholding
01 May 2013 07:03 AM
RNS
Collaboration with Novartis
17 Apr 2013 01:00 PM
RNS
2012 ANNUAL REPORT & ACCOUNTS & AGM NOTIFICATION
07 Mar 2013 07:00 AM
RNS
Initiation of PII Collaborative Study for TroVax
27 Feb 2013 07:00 AM
RNS
Preliminary Results
25 Jan 2013 04:40 PM
RNS
Second Price Monitoring Extn
25 Jan 2013 04:35 PM
RNS
Price Monitoring Extension
23 Jan 2013 07:00 AM
RNS
Notice of Preliminary Results
29 Nov 2012 07:00 AM
RNS
Exercise of Option by ImaginAb
28 Nov 2012 07:00 AM
RNS
Block Listing Return
20 Nov 2012 07:00 AM
RNS
Ocular Clinical Programme Update
14 Nov 2012 07:00 AM
RNS
Interim Management Statement
09 Nov 2012 07:00 AM
RNS
Issue of Key US Patent
10 Oct 2012 07:00 AM
RNS
Update on TroVax (R) Development Strategy
03 Oct 2012 07:00 AM
RNS
Board Change
27 Sep 2012 08:00 AM
RNS
Collaboration With Immune Design Corp.
26 Sep 2012 04:40 PM
RNS
Second Price Monitoring Extn
26 Sep 2012 04:35 PM
RNS
Price Monitoring Extension
14 Sep 2012 04:40 PM
RNS
Second Price Monitoring Extn
14 Sep 2012 04:35 PM
RNS
Price Monitoring Extension
10 Sep 2012 12:20 PM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
31 Aug 2012 07:00 AM
RNS
Interim Results
29 Aug 2012 02:00 PM
RNS
Oxford BioMedica to Present at Conference
10 Aug 2012 11:06 AM
RNS
Block Listing Return
08 Aug 2012 08:00 AM
RNS
Positive DSMB Review of Ongoing Clinical Studies
30 Jul 2012 11:59 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27 Jul 2012 09:44 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
26 Jul 2012 05:26 PM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
25 Jul 2012 11:47 AM
RNS
Result of EGM
25 Jul 2012 07:00 AM
RNS
Notice of Interim Results
25 Jul 2012 07:00 AM
RNS
Results of Firm Placing and Open Offer
23 Jul 2012 07:00 AM
RNS
Funding Award for UshStat(R) Phase I/IIa study
19 Jul 2012 04:40 PM
RNS
Second Price Monitoring Extn
19 Jul 2012 04:35 PM
RNS
Price Monitoring Extension
10 Jul 2012 07:00 AM
RNS
Initiation of Phase II Collaborative Study
06 Jul 2012 01:02 PM
RNS
Notice of posting of prospectus
02 Jul 2012 07:00 AM
RNS
Directors' Interest in Shares and Share Options
29 Jun 2012 07:00 AM
RNS
Proposed Firm Placing and Open Offer

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100